Partners AMR Insights

The NIH NIAID program, “Chemistry Center for Combatting Antibiotic Resistant Bacteria” (CC4CARB) is an innovative chemistry center focused on the synthesis and delivery of rationally designed, focused libraries for the scientific community to use in Gram-negative antibacterial drug discovery. The ultimate objective of CC4CARB is to create a large collection of chemical matter specifically targeting Gram-negative threats.

NIAID and RTI welcome you to participate in CC4CARB as we are currently accepting scaffold proposals. Additional information on CC4CARB can be found on the program website.

Evotec is a life science company with a unique business model focused on delivering highly effective new therapeutics to the patients. The Company leverages its multimodality platform, the “Data-driven R&D Autobahn to Cures”, for proprietary projects and within a network of partners including Pharma, Biotech, academics, and other healthcare stakeholders. With more than 4,200 highly qualified people at 15 sites, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics. For additional information please go to www.evotec.com and follow us on Twitter @Evotec and LinkedIn.

Addressing the human health impacts of AMR will require building a strong and motivated coalition of like-minded health officials, clinicians, laboratorians, policymakers, patients and leaders.

NYtor (2007) designs and (co-)develops smart, molecular assays for detecting antibiotic resistance in human and veterinary diagnostics. Design and co-development take place in close collaboration with customers, selected suppliers and global partners. NYtor also produces its prototype assays.

To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.

Affidia Journal (by Affidia Srl benefit company) is an independent publication in the field of food safety and food testing. Affidia Journal aims to provide food business owners, food safety and laboratory managers with high-level scientific/technical/regulatory information. The journal covers all the major topics, accepting scientific and technical contributions by a variety of academic and private sources, always with clear distinction between scientific information and products/services promotion. Affidia’s vision is that safe food produced in an ethical and sustainable way should be a right for all people in the world, therefore, we are committed to report what is happening in Europe and other well-developed countries, as well as in low-income ones.